ALGN: Invisalign Expansion and Cash Strength Offset ASP Headwinds

What happened

Align Technology continues to expand Invisalign globally and sees strong adoption of its iTero Lumina scanner, backed by $1.06B in cash, yet management guides for a 1-2% decline in 2026 average selling prices. This combination of volume growth and pricing pressure is consistent with the company's recent performance, where Q3 2025 clear-aligner cases rose 4.9% year-over-year while non-GAAP operating margins improved to 23.9%. The upcoming Q4 2025 earnings and initial 2026 guidance will be critical to validate whether restructuring savings can offset ASP erosion and sustain margins above 22%. Our base-case valuation of $205 assumes 4-5% annual case growth and stable margins, but the bear case of $135 remains if ASP declines accelerate or volumes disappoint.

Implication

Investors should monitor Q4 2025 earnings for margin delivery and 2026 guidance. If volumes meet mid-single-digit growth and non-GAAP margins exceed 22%, the stock offers 15-25% upside. However, if ASP erosion or competitive pressure pushes margins below 22%, a reversion to bear-case levels is possible.

Thesis delta

The Zacks article does not alter our thesis; it reinforces the narrative of volume growth and cash strength but does not address the critical margin and ASP challenges. The primary swing factor remains whether Align can sustain non-GAAP operating margins above 22% given 1-2% ASP headwinds. No change to the POTENTIAL BUY rating with $205 base case.